Prescribing guidance from the General Medical Council states that ‘You must be prepared to explain and justify your decisions and actions when prescribing, administering and managing medicines’. This is particularly pertinent for drugs that are associated with a risk of dependency.
Get full access to this article
View all access options for this article.
References
1.
AdamsE. H.BreinerS.CiceroT. J.GellerA.InciardiJ. A.SchnollS. H.WoodyG. E. (2006) A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. Journal of Pain and Symptom Management31(5): 465–476. doi: 10.1016/j.jpainsymman.2005.10.006.
2.
Anon (2004) What's wrong with prescribing hypnotics?Drug and Therapeutics Bulletin42(12): 89–93. doi: 10.1136/dtb.2004.421289.
3.
AshtonH. (2005) The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry18(3): 249–255.
AyevardP.Lindson-HawleyN.HastingsG.de AndradeM. (2014) Should smokers be advised to cut down as well as quit?British Medical Journal348: G2787doi: 10.1136/bmj.g2787.
BPS. (2007). Pain and substance misuse: Improving the patient experience. A consensus statement prepared by The British Pain Society in collaboration with The Royal College of Psychiatrists, The Royal College of General Practitioners and The Advisory Council on the Misuse of Drugs. April 2007. Section 1.3, pages 7-8. Retrieved from http://www.britishpainsociety.org/book_drug_misuse_main.pdf.
8.
ElanderJ.DuarteJ.MaratosF. A.GilbertP. (2006) Predictors of painkiller dependence among people with pain in the general population. Journal of Pain and Symptoms Management31(5): 465–476. doi: 10.1016/j.jpainsymman.2005.10.006.
HajekP.McRobbieH.GillisonF. (2007) Dependence potential or nicotine replacement treatment: Effects of product type, patients characteristics and cost to use. Preventive Medicine44(3): 230–234.
11.
Lingford-HughesA. R.WelchS.PetersL.NuttD. J.British Association for Psychopharmacology, Expert Reviewers Group (2012) BAP updated guidelines: Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: Recommendations from BAP. Journal of Psychopharmacology26(7): 899–952. doi: 10.1177/0269881112444324.
12.
McCarthyM. (2012) Containing the opioid overdose epidemic. British Medical Journal345: e8340.
13.
McLellanT.LewisD.O’BrienC.KleberH. (2000) Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association284(13): 1689–1695. doi: 10.1001/jama.284.13.1689.
SiriwardenaA. N.QureshiZ.GibsonS.CollierS.LathamM. (2006) GPs' attitudes to benzodiazepine and ‘z-drug' prescribing: A barrier to implementation of evidence and guidance on hypnotics. British Journal of General Practice56(533): 964–967. Retrieved from http://bjgp.org/content/56/533/964.full.pdf+html.
